Zurich (Switzerland), - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced ...

A study shows that cinnamaldehyde in cinnamon supplements can activate drug-processing pathways, potentially affecting how ...

Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets ...

An editorial published in Brain Medicine reveals that many widely prescribed medications may disrupt sterol biosynthesis—an ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...

Discover how excess weight silently damages your joints through both mechanical stress and inflammation, and learn effective ...

That is often viewed by us profligate, protein-burning, fat-loving energy spendthrifts as an inferior form of metabolism. But ...

Northwestern Medicine investigators have discovered how disruptions in the circadian rhythm in our muscles combined with poor ...

Galmed Pharmaceuticals Ltd. ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company, today announced a sponsored research collaboration with Virginia Commonwealth University (VCU) to ...

In the global carbon cycle microorganisms have evolved a variety of methods for fixing carbon. Researchers have investigated the methods that are utilized at extremely hot, acidic and sulfur-rich ...

In the global carbon cycle, microorganisms have evolved a variety of methods for fixing carbon. Researchers from Bremen and ...

The successful candidate will be involved in teaching and developing undergraduate and graduate-level courses such as Clinical Biochemistry, Metabolic diseases, Medical Microbiology, Immunology, ...